MK-7 Synthesis Route Without Chromatographic Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for synthesizing menaquinone MK-7 face challenges such as low yield, high costs, and the need for tedious chromatographic purification steps, with existing methods failing to achieve high isomeric purity and scalability on an industrial scale.
Innovation Solution
A method involving the coupling of a menadiol derivative with an isoprene chain using cheap and easily available reagents, followed by desulfonylation and oxidation steps, eliminates the need for column chromatography and achieves high yield and purity, allowing for crystalline product formation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional Friedel-Crafts reaction is used to couple menadiol derivative with isoprene chain, then reaction can be performed, but product is obtained as E/Z mixture requiring column chromatography for purification
Solution Approach 1:
The patent changes the reaction parameters by using specific Lewis acids (BF3·Et2O, AlCl3) and controlling reaction conditions (temperature, solvent choice) to achieve selective formation of E-isomer. This parameter optimization eliminates the need for chromatographic purification by ensuring high isomeric purity is obtained directly from the reaction.
2Manufacturing precision
If multi-step synthesis with chromatography is used, then high isomeric purity can be achieved, but production cost and time increase
Solution Approach 1:
The patent extracts and eliminates the chromatography step from the synthesis process by optimizing the coupling reaction conditions. By using specific Lewis acids and controlling reaction parameters, the method achieves direct formation of pure E-isomer without requiring time-consuming purification steps, thus reducing both time and cost.
3Manufacturing precision
If column chromatography is used for product isolation, then purity is improved, but yield is reduced and production cost increases
Solution Approach 1:
The patent converts the potential harm of mixture formation into a benefit by using reaction conditions that selectively favor E-isomer formation. The Lewis acid-catalyzed coupling is optimized to produce high E/Z ratios (up to 20:1), where the 'mixture' is actually dominated by the desired isomer, eliminating purification needs and preserving yield.
4Productivity
If expensive catalysts and reagents are used, then reaction efficiency improves, but production cost increases
Solution Approach 1:
The patent employs inexpensive, readily available Lewis acids such as boron trifluoride etherate and aluminum chloride as catalysts. These cheap, easily obtainable reagents achieve high reaction efficiency and E-isomer selectivity without requiring expensive rare earth metal catalysts or specialized reagents, thus reducing production costs while maintaining productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides a high-yield, cost-effective synthesis of MK-7 on an industrial scale, eliminating the need for tedious chromatographic purification and achieving high isomeric purity, thus improving scalability and reducing production costs.
Implementation Method 1
coupling a compound of formula (11) with a compound of formula (17) in the presence of a base, to obtain a compound of formula (18)
Implementation Method 2
which is subjected to desulfonylation reaction in the presence of a palladium catalyst, to obtain a compound of formula (19)
Implementation Method 3
which is subjected to an oxidation reaction, to obtain the menaquinone of formula (20)
Data Source
AI summary
The invention relates to a method and intermediate compounds for the preparation of menaquinone MK-7. The method for the preparation of menaquinone MK-7 is characterized in that, it comprises coupling of a compound of formula (11) with a compound of formula (17) in the presence of a base, to obtain a compound of formula (18), which is subjected to desulfonylation reaction in the presence of a palladium catalyst, to obtain a compound of formula (19), which is subjected to oxidation reaction, to obtain menaquinone MK-7. The invention also relates to compound (8), preferably in a crystalline form, which is a convenient intermediate compound for the preparation of menaquinone MK-7.